Arillotta, D., Floresta, G., Guirguis, A., et al
GLP-1 slows gastric emptying, which can delay or reduce absorption of oral supplements
In his view, this drug class has the potential to be a breakthrough treatment for people with alcohol problems
In the SURMOUNT-5 trial, which directly compared the two, Mounjaro produced a 20.2% weight loss, compared with 13.7% for semaglutide 2.4 mg over 72 weeks
Injectable semaglutide and tirzepatide compounds offer consistent drug exposure that oral formats cannot match
Getting enough sleep is a critical part of sleep health, but the quality and timing of your sleep are equally important